APA

Baz R., Walker E., Karam M. A., Choueiri T. K., Jawde R. A., Bruening K., Reed J., Faiman B., Ellis Y., Brand C., Srkalovic G., Andresen S., Knight R., Zeldis J. & Hussein M. A. (20070301). Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Baz R, Walker E, Karam M A, Choueiri T K, Jawde R A, Bruening K, Reed J, Faiman B, Ellis Y, Brand C, Srkalovic G, Andresen S, Knight R, Zeldis J and Hussein M A. 20070301. Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Baz R., Walker E., Karam M. A., Choueiri T. K., Jawde R. A., Bruening K., Reed J., Faiman B., Ellis Y., Brand C., Srkalovic G., Andresen S., Knight R., Zeldis J. and Hussein M. A. (20070301). Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Baz R, Walker E, Karam M A, Choueiri T K, Jawde R A, Bruening K, Reed J, Faiman B, Ellis Y, Brand C, Srkalovic G, Andresen S, Knight R, Zeldis J and Hussein M A. Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy. : Annals of oncology : official journal of the European Society for Medical Oncology. 20070301.